Clinical trials
Completed Observational Hematologic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
119 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2003 | 1 |
| 2004 | 2 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 6 |
| 2013 | 6 |
| 2014 | 5 |
| 2015 | 10 |
| 2016 | 11 |
| 2017 | 6 |
| 2018 | 4 |
| 2019 | 9 |
| 2020 | 10 |
| 2021 | 15 |
| 2022 | 6 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 119 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| St. Jude Children's Research Hospital | 7 |
| M.D. Anderson Cancer Center | 6 |
| University of California, San Francisco | 6 |
| Fred Hutchinson Cancer Center | 3 |
| Janssen Korea, Ltd., Korea | 3 |
| Thomas Jefferson University | 3 |
| UNC Lineberger Comprehensive Cancer Center | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Beckman Coulter, Inc. | 2 |
| Celgene | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 119 |
| Neoplasms | 13 |
| Lymphoma | 11 |
| Multiple Myeloma | 11 |
| Leukemia, Myeloid, Acute | 10 |
| Neutropenia | 10 |
| COVID-19 | 9 |
| Leukemia | 9 |
| Myelodysplastic Syndromes | 8 |
| Graft vs Host Disease | 5 |
Trials
Showing 1 to 25 of 119. Each trial links to its page on Pharma Observatory.
19 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.